Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 1
2006 1
2007 2
2009 3
2010 4
2011 7
2012 7
2013 5
2014 3
2015 2
2017 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.
Connell SP, Yazbek-Hanna M, McCarthy F, Hurst R, Webb M, Curley H, Walker H, Mills R, Ball RY, Sanda MG, Pellegrini KL, Patil D, Perry AS, Schalken J, Pandha H, Whitaker H, Dennis N, Stuttle C, Mills IG, Guldvik I; Movember GAP1 Urine Biomarker Consortium; Parker C, Brewer DS, Cooper CS, Clark J. Connell SP, et al. BJU Int. 2019 Oct;124(4):609-620. doi: 10.1111/bju.14811. Epub 2019 Jun 25. BJU Int. 2019. PMID: 31106513 Free PMC article.
Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
Sequeiros T, Rigau M, Chiva C, Montes M, Garcia-Grau I, Garcia M, Diaz S, Celma A, Bijnsdorp I, Campos A, Di Mauro P, Borrós S, Reventós J, Doll A, Paciucci R, Pegtel M, de Torres I, Sabidó E, Morote J, Olivan M. Sequeiros T, et al. Among authors: doll a. Oncotarget. 2017 Jan 17;8(3):4960-4976. doi: 10.18632/oncotarget.13634. Oncotarget. 2017. PMID: 27903962 Free PMC article.
Biomarker and translational prostate cancer research.
Doll A, Clark J, Nelson C. Doll A, et al. Biomed Res Int. 2015;2015:309851. doi: 10.1155/2015/309851. Epub 2015 Jan 15. Biomed Res Int. 2015. PMID: 25664317 Free PMC article. No abstract available.
MicroRNAs as prognostic markers in ovarian cancer.
Llauradó M, Majem B, Altadill T, Lanau L, Castellví J, Sánchez-Iglesias JL, Cabrera S, De la Torre J, Díaz-Feijoo B, Pérez-Benavente A, Colás E, Olivan M, Doll A, Alameda F, Matias-Guiu X, Moreno-Bueno G, Carey MS, Del Campo JM, Gil-Moreno A, Reventós J, Rigau M. Llauradó M, et al. Among authors: doll a. Mol Cell Endocrinol. 2014 Jun 5;390(1-2):73-84. doi: 10.1016/j.mce.2014.03.006. Epub 2014 Apr 18. Mol Cell Endocrinol. 2014. PMID: 24747602 Review.
[Molecular biology of bone metastases].
Doll A, García M, Rigau M, Olivan M, Montes M, Sequeiros T, Llaurado M, Colás E, Reventós J, Morote J. Doll A, et al. Arch Esp Urol. 2013 Jun;66(5):463-74. Arch Esp Urol. 2013. PMID: 23793764 Review. Spanish.
The present and future of prostate cancer urine biomarkers.
Rigau M, Olivan M, Garcia M, Sequeiros T, Montes M, Colás E, Llauradó M, Planas J, Torres Id, Morote J, Cooper C, Reventós J, Clark J, Doll A. Rigau M, et al. Among authors: doll a. Int J Mol Sci. 2013 Jun 17;14(6):12620-49. doi: 10.3390/ijms140612620. Int J Mol Sci. 2013. PMID: 23774836 Free PMC article. Review.
33 results